NJBAC’s Cannabis Training Academy welcomed their first set of instructors to the program.
In a recent press release from the Department of State (DOS) (1), mentioned that the New Jersey Business Action Center (NJBAC) picked their first set of instructors for the Cannabis Training Academy (CTA) which will help the state’s technical assistance program.
The CTA is due to launch in 2024. Communities that have been “disproportionately impacted” from cannabis or are located within “designated Impact Zones” will be provided with information to obtain an adult-use cannabis operator’s license by the CTA (1). The program will educate students with instructors who teach or work in the New Jersey cannabis industry and also be a tool on whether the cannabis industry is the best fit for them.
“We look forward to launching the Cannabis Training Academy in 2024. This program will build upon the work happening throughout state government to create a more equitable, inclusive, and diverse cannabis industry,” Lieutenant Governor Tahesha Way expressed, Secretary of State in New Jersey (1).
“Our goal is to provide key support to Jersey-owned, Jersey-local, entrepreneurs who are interested in pursuing a recreational cannabis license through this virtual technical assistance program,” Melanie Willoughby, NJBAC Executive Director, said (1). “We are proud to provide resources and support to budding cannabis entrepreneurs and current local operators who are striving to make a positive impact in their communities.”
“The New Jersey cannabis community is an important partner to build out this academy,” Penni Wild, NJBAC Deputy Executive Director, commented (1). “More than 250 people formally expressed interest in applying to be a CTA instructor. After three months of screening, vetting and interviews, the first 25 instructors have been selected to help us initiate and launch this first-of-its kind cannabis technical assistance program in New Jersey.”
“Each of our selected instructors bring years of experience, success, some painful lessons learned, and deep insight to budding entrepreneurs who are interested in stepping into the Garden State’s cannabis industry,” Tauhid Chappell CTA Executive Director, explained (1). “Many have personally written and submitted applications for, and have succeeded in winning, cannabis licenses in New Jersey and/or other states too. This wealth of knowledge gives us confidence that prospective CTA students will be getting the most relevant, on-the-ground, guidance and wisdom from those who’ve been through the exact process and know what it takes to enter and thrive in this industry.”
As mentioned in the press release, the 25 CTA instructors along with their designated courses are (1):
The CTA program will be offered at no-cost to state residents that are 21 years old and up. To learn more about the program through New Jersey’s Department of State press release (1), click here.
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.